Sino Biopharmaceutical (01276.HK): The actual unlocked shares during the third lock-up period of the employee stock ownership plan in 2022 totaled 2.8303 million shares.

News from the Securities Times app, Hengrui Medicine (01276.HK) announced that as of the disclosure date of this announcement, a total of 2.8303 million shares (0.04% of the company's total share capital) under the third lock-up period of the company's 2022 employee stock ownership plan have been unlocked. As of November 14, 2025, 1.6568 million shares have been transferred to the participants of the employee stock ownership plan, and 1.1735 million shares have been sold through centralized auction trading. The company's Employee Stock Ownership Plan Management Committee will carry out corresponding property distribution work in accordance with the relevant provisions of this employee stock ownership plan.